Zentrum fuer Tumordiagnostikund Praevention
Welcome,         Profile    Billing    Logout  
 2 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Honecker, Friedemann
ISCA-CHECK, NCT06408688: Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors

Recruiting
4
100
Europe
Immune checkpoint inhibitors plus Iscador® Qu., Immune Checkpoint Inhibitors
University Hospital, Basel, Switzerland
Advanced Solid Tumor
11/26
11/26
SAKK 95/17, NCT03786198: Activity Program During Aromatase Inhibitor Therapy

Completed
3
375
Europe
Activity program, Control
Swiss Group for Clinical Cancer Research
Early Breast Cancer
09/21
06/23

Download Options